Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
June's biggest stories: More than 68,000 stents recalled | Marijuana use & heart rhythm issues | Much more!
Thursday, June 30, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo
Congrats! July is almost here, which means you made it through another month. Recalls hit the cardiovascular space in a big way in June, but those weren't the only stories that gained attention. Our readers also wanted to learn more about the potential impact marijuana use is having on the heart health of older patients and how to maintain high-quality patient care during the ongoing contrast shortage. In addition, we spent time this month looking at some of the biggest news coming out of SCAI 2022 and TVT 2022. Browse the stories below to catch up. As always, thanks for reading!

The Month in Review

More than 68,000 stents recalled after multiple injuries

Dozens of customers have reported issues with the device’s balloon or catheter hub separating from the delivery system, mostly during off-label use in a patient's blood vessels.

READ MORE >
The Advanta V12 and iCast (bottom image) balloon expandable covered stents were recalled by Atrium/Getinge because the balloons may not deflate quickly when using thicker contrast for endovascular use.
Share on Twitter Share on Facebook Share on Linkedin

More than 68,000 stents recalled after multiple injuries

Share on Twitter Share on Facebook Share on Linkedin
The Advanta V12 and iCast (bottom image) balloon expandable covered stents were recalled by Atrium/Getinge because the balloons may not deflate quickly when using thicker contrast for endovascular use.
Dozens of customers have reported issues with the device’s balloon or catheter hub separating from the delivery system, mostly during off-label use in a patient's blood vessels.
READ MORE >

FDA announces another recall for troubled heart device after a patient death

This latest recall involves the device's batteries, which are separating due to a "welding defect." 

READ MORE >
Product Recall
Share on Twitter Share on Facebook Share on Linkedin

FDA announces another recall for troubled heart device after a patient death

Share on Twitter Share on Facebook Share on Linkedin
Product Recall
This latest recall involves the device's batteries, which are separating due to a "welding defect." 
READ MORE >

Marijuana use linked to heart rhythm issues in older adults

Former users, however, do not seem to face the same risks as current users. 

READ MORE >
Marijuana use among older adults is associated with a heightened risk of atrial and ventricular arrhythmias, according to new research published in the American Journal of Cardiology. “Marijuana use increases sympathetic nervous system activity and inhibits cardiac parasympathetic innervation, resulting in elevated heart rate, elevated blood pressure, and an increase in myocardial oxygen demand.
Share on Twitter Share on Facebook Share on Linkedin

Marijuana use linked to heart rhythm issues in older adults

Share on Twitter Share on Facebook Share on Linkedin
Marijuana use among older adults is associated with a heightened risk of atrial and ventricular arrhythmias, according to new research published in the American Journal of Cardiology. “Marijuana use increases sympathetic nervous system activity and inhibits cardiac parasympathetic innervation, resulting in elevated heart rate, elevated blood pressure, and an increase in myocardial oxygen demand.
Former users, however, do not seem to face the same risks as current users. 
READ MORE >

The top 10 children’s hospitals for cardiology and heart surgery

The 2022-2023 rankings include some familiar names at the top. Did your facility make the cut? 

READ MORE >
U.S. News & World Report children’s hospitals cardiology heart surgery. SCAI said the Accelerating Kids' Access to Care Act would make it easier for children to access pediatric cardiology specialists in neighboring states when none are in their state, or out-of-state doctors are closer.
Share on Twitter Share on Facebook Share on Linkedin

The top 10 children’s hospitals for cardiology and heart surgery

Share on Twitter Share on Facebook Share on Linkedin
U.S. News & World Report children’s hospitals cardiology heart surgery. SCAI said the Accelerating Kids' Access to Care Act would make it easier for children to access pediatric cardiology specialists in neighboring states when none are in their state, or out-of-state doctors are closer.
The 2022-2023 rankings include some familiar names at the top. Did your facility make the cut? 
READ MORE >

7 ways cath labs can work through the contrast media shortage without delays

When the ongoing contrast media shortage first started impacting health systems, one group in Ohio pledged not to delay a single procedure in its cath labs.

READ MORE >
contrast shortage
Share on Twitter Share on Facebook Share on Linkedin

7 ways cath labs can work through the contrast media shortage without delays

Share on Twitter Share on Facebook Share on Linkedin
contrast shortage
When the ongoing contrast media shortage first started impacting health systems, one group in Ohio pledged not to delay a single procedure in its cath labs.
READ MORE >

Key interventional cardiology takeaways from the SCAI 2022 conference

The key interventional cardiology takeaways from sessions presented at the Society for Cardiovascular Angiography and Interventions (SCAI) 2022 annual meeting.

READ MORE >
Early clinical evaluation of the Alleviant System to create no-implant interatrial shunts to treat heart failure patients with preserved and reduced ejection fraction (HFpEF and HFrEF) demonstrated procedural safety and feasibility with a promising efficacy signal through six months.
Share on Twitter Share on Facebook Share on Linkedin

Key interventional cardiology takeaways from the SCAI 2022 conference

Share on Twitter Share on Facebook Share on Linkedin
Early clinical evaluation of the Alleviant System to create no-implant interatrial shunts to treat heart failure patients with preserved and reduced ejection fraction (HFpEF and HFrEF) demonstrated procedural safety and feasibility with a promising efficacy signal through six months.
The key interventional cardiology takeaways from sessions presented at the Society for Cardiovascular Angiography and Interventions (SCAI) 2022 annual meeting.
READ MORE >

VIDEO: Transcatheter tricuspid devices likely to gain FDA clearance before new mitral advances

It was clear at TVT that tricuspid valve therapies will likely move ahead of new mitral therapies coming to market. Azeem Latib, MD, explained why.

READ MORE >
Azeem Latib explains advances in transcatheter mitral and tricuspid valve therapies at TVT 2022. #TVT #TVT22 #TVT2022 #TMVR #TTVR
Share on Twitter Share on Facebook Share on Linkedin

VIDEO: Transcatheter tricuspid devices likely to gain FDA clearance before new mitral advances

Share on Twitter Share on Facebook Share on Linkedin
Azeem Latib explains advances in transcatheter mitral and tricuspid valve therapies at TVT 2022. #TVT #TVT22 #TVT2022 #TMVR #TTVR
It was clear at TVT that tricuspid valve therapies will likely move ahead of new mitral therapies coming to market. Azeem Latib, MD, explained why.
READ MORE >

Links to all the late-breaking structural heart studies at TVT 2022

Here are links to more information for all the late-breaking presentations at the 2022 Transcatheter Valve Therapies (TVT) Structural Heart Summit.

READ MORE >
A Medtronic Evolut Corevalve TAVR valve in use at Emory.
Share on Twitter Share on Facebook Share on Linkedin

Links to all the late-breaking structural heart studies at TVT 2022

Share on Twitter Share on Facebook Share on Linkedin
A Medtronic Evolut Corevalve TAVR valve in use at Emory.
Here are links to more information for all the late-breaking presentations at the 2022 Transcatheter Valve Therapies (TVT) Structural Heart Summit.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

TAVR for moderate aortic stenosis | BP drug recalled | Stroke prevention device fails | New Medicare cuts | CCTA-guided PCI
A new way to think about the heart health of women | GLP-1 drugs vs. metformin | Cannabis use may increase risk of CVD, stroke
New Medicare payment cuts | Telemedicine vs. in-person cardiology visits | FDA confirms Class I recall | Startup raises $160M
FDA approves transcatheter treatment for PVL | CCTA-guided PCI | Real-world RDN outcomes | J&J launches new IVL catheter
CCTA vs. IVUS for PCI guidance: Carlos Collet reviews the data | The real-world benefits of RDN | New TAVR tech falls short
TAVR Highlights: New data on treating moderate AS | CMS may expand coverage again | Is surgical backup still necessary?
GLP-1 drugs vs. metformin | BP drug recalled | The health risks of cannabis use | Energy drinks linked to heart issues
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme